ARK Genomic Revolution ETF vs Ryanair Holdings plc — how do they compare? ARK Genomic Revolution ETF trades at $44.5, while Ryanair Holdings plc trades at $60.03 (market cap $29.63B). The key difference: Ryanair Holdings plc pays a 1.51% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Ryanair Holdings plc nearer its low. Which is the better fit depends on your goals.
| ARKG | RYAAY | |
|---|---|---|
Sector | Sector/Thematic | Industrials |
52-Week High | $44.55 | $73.82 |
52-Week Low | $24.02 | $53.24 |
Market Cap | — | $29.63B |
Enterprise Value | — | $26.61B |
Dividend Yield | — | 1.51% |
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Ryanair is the leading airline group by passenger numbers in Europe. The company employs a low-cost no-frills model to offer low fares to leisure customers on short-haul intra-European routes. In 2020, the most recent pre-pandemic fiscal year, the company carried 149 million passengers, utilizing a fleet of 467 Boeing 737 aircraft across its 1,800 routes. To keep costs low the company serves predominantly lower-cost secondary airports. The company generated sales of EUR 8.5 billion in fiscal 2020.
Read more on RYAAY →